Surging Ahead: ImmunityBio’s (IBRX) Momentum Persists
ImmunityBio, Inc. (NASDAQ: IBRX) appears to be sustaining the momentum from yesterday’s surge as it enters today’s trading session. As of the last check, INRX shares were observed trading 5.69% higher at $9.48, following a 5.09% increase in the previous session, closing at $8.97. This notable uptick follows an exclusive agreement for global supply. ImmunityBio […]
